Altimmune Inc

Moving to advance its leadership in developing vaccines for important public health and biodefense needs, Altimmune Inc. announced (17/02/2015) that it has entered into a definitive agreement to acquire Immune Targeting Systems (ITS) Ltd. Altimmune is a clinical stage vaccine development company headquartered in Gaithersburg, Maryland. ITS develops novel T-cell vaccines at its operations in the United Kingdom and France. The deal is an all-stock transaction and the combined company will be known as Vaxin Inc.

Year founded

1992

altimmune.com